企業プロフィール
Graphite Bio 株価・ニュース・カタリスト
- ティッカー:
- GRPH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for GRPH.
企業概要
事業概要
Graphite Bio was a gene-editing company focused on precision genome correction before its public-market wind-down. Its story was built around advanced editing science and rare-disease targets.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before restructuring, Graphite sat in gene-editing biotechnology.
ビジネスモデルの特徴
The business depended on clinical and translational validation, as well as the feasibility of its editing approach.
バイオ業界での位置付け
Graphite Bio is now best treated as a historical gene-editing case rather than a live catalyst name.
今後のカタリスト
- Graphite Bio is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than fresh pipeline news. The market no longer treats it like a live standalone development story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。